Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

0.89
Delayed Data
As of Feb 12
 +0.0149 / +1.70%
Today’s Change
0.76
Today|||52-Week Range
6.28
-42.21%
Year-to-Date
No recent news for ContraVir Pharmaceuticals Inc.

Today’s Trading

Previous close0.88
Today’s open0.87
Day’s range0.86 - 0.95
Volume50,685
Average volume (3 months)677,791
Market cap$24.3M
Dividend yield--
Data as of 3:58pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-148.78%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CBIOCatalyst Biosciences...+0.22+10.95%
PARNParnell Pharmaceutic...-0.12-6.42%
ZSANZosano Pharma Corp+0.11+5.47%
ACURAcura Pharmaceutical...+0.01+0.46%
Data as of 3:59pm ET, 02/12/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$14.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
James E. Sapirstein
Chief Medical Officer
John Z. Sullivan-Bólyai
Corporate headquarters
Edison, New Jersey

Forecasts

Partner Offers